Bob Horvitz from Cancer to Brain Research: Learning from Worms from the Director
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
USA Education Ph.D., Biology, Massachusetts Institute of Tech
Victor R. Ambros, Ph.D. Silverman Professor of Natural Sciences Program in Molecular Medicine University of Massachusetts Medical School373 Plantation Street, Suite 306 Worcester, MA 01605 (508) 856-6380 [email protected] Personal Born: Hanover, NH, USA on December 1, 1953 Citizenship: USA Education Ph.D., Biology, Massachusetts Institute of Technology, Cambridge, MA 1976-1979 Thesis Title: The protein covalently linked to the 5' end of poliovirus RNA Advisor: Dr. David Baltimore B.S., Biology, Massachusetts Institute of Technology, Cambridge, MA 1971-1975 Professional Appointments Silverman Professor of Natural Sciences 2009-present Co-Director, RNA Therapeutics Institute 2009-2016 Professor, Program in Molecular Medicine 2008-present University of Massachusetts Medical School, Worcester, MA Professor of Genetics, Dartmouth Medical School 2001-2007 Professor, Biological Sciences, Dartmouth Medical School 1996-2001 Associate Professor, Biological Sciences, Dartmouth Medical School 1992-1996 Associate Professor, Department of Cellular and Development Biology, 1988-1992 Harvard University, Cambridge, MA Assistant Professor, Department of Cellular and Development Biology, 1985-1988 Harvard University, Cambridge, MA Postdoctoral Research 1979-1985 Supervisor: Dr. H. Robert Horvitz Massachusetts Institute of Technology, Cambridge, MA Graduate Research 1976-1979 Supervisor: Dr. David Baltimore Massachusetts Institute of Technology, Cambridge, MA Research Assistant 1975-1976 Supervisor: Dr. David Baltimore Center for Cancer Research, -
Nobel Laureates Endorse Joe Biden
Nobel Laureates endorse Joe Biden 81 American Nobel Laureates in Physics, Chemistry, and Medicine have signed this letter to express their support for former Vice President Joe Biden in the 2020 election for President of the United States. At no time in our nation’s history has there been a greater need for our leaders to appreciate the value of science in formulating public policy. During his long record of public service, Joe Biden has consistently demonstrated his willingness to listen to experts, his understanding of the value of international collaboration in research, and his respect for the contribution that immigrants make to the intellectual life of our country. As American citizens and as scientists, we wholeheartedly endorse Joe Biden for President. Name Category Prize Year Peter Agre Chemistry 2003 Sidney Altman Chemistry 1989 Frances H. Arnold Chemistry 2018 Paul Berg Chemistry 1980 Thomas R. Cech Chemistry 1989 Martin Chalfie Chemistry 2008 Elias James Corey Chemistry 1990 Joachim Frank Chemistry 2017 Walter Gilbert Chemistry 1980 John B. Goodenough Chemistry 2019 Alan Heeger Chemistry 2000 Dudley R. Herschbach Chemistry 1986 Roald Hoffmann Chemistry 1981 Brian K. Kobilka Chemistry 2012 Roger D. Kornberg Chemistry 2006 Robert J. Lefkowitz Chemistry 2012 Roderick MacKinnon Chemistry 2003 Paul L. Modrich Chemistry 2015 William E. Moerner Chemistry 2014 Mario J. Molina Chemistry 1995 Richard R. Schrock Chemistry 2005 K. Barry Sharpless Chemistry 2001 Sir James Fraser Stoddart Chemistry 2016 M. Stanley Whittingham Chemistry 2019 James P. Allison Medicine 2018 Richard Axel Medicine 2004 David Baltimore Medicine 1975 J. Michael Bishop Medicine 1989 Elizabeth H. Blackburn Medicine 2009 Michael S. -
Of Charles D. Ferguson, on Behalf Of
FEDERATION OF AMERICAN SCIENTISTS T: 202/546-3300 1725 DeSales Street, NW 6th Floor Washington, DC 20036 www.fas.org F: 202/675-1010 [email protected] PRM-70-9 DOCKETED Board of Sponsors (75FR80730) USNRC (PartialList) March 4, 2011 March 7, 2011 (10:30 am) •Pacr Agre * SidnheyAman * Philip W. Anderson *Kenneth J. Arrow To: Secretary, U.S. Nuclear Regulatory Commission OFFICE OF SECRETARY * David Baltimore RULEMAKINGS AND * Bamj Be.....ea Washington, DC 20555-0001 SPaulBerg ADJUDICATIONS STAFF * J. Michael Bishop AT-TN: Rulemakings and Adjudications Staff * Guther Blobel * Nicolaas Bloensbergen * Paul Boyce Ann Pitts Carter Subject: Comment on Docket ID NRC-2010-0372, "Petition for Rulemaking, * Stanley Cohen * Leon N. Cooper Francis Slakey on Behalf of the American Physical Society" * E. J. Corey 'James Cronin * Johann Deismehofer ArmDruyan *RenatoDulbeomo As Board Members of the Federation of American Scientists, an independent, Paul L Ehrlich George Field nonpartisan think tank, we strongly support the petition submitted by the Vat L. Fitch * JeromeI. Friedman American Physical Society that requests proliferation risk assessments become a * Riccardo Giacoani * Walter Gilbert required part of the NRC licensing process. * Alfed G. Gilman " Donald Glaser * Sheldon L. Glashow Marvin L. Goidhergr * Joseph L. Goldstein Emerging nuclear fuel technologies such as laser enrichment of uranium can pose Roger C. L. Gaillemin * L[land H. Hartwell significant proliferation risks due to difficulties in detecting facilities using these * Herbert A. Hauptman " Dudley RKHIaechach technologies. If such technologies are developed without a clear, objective, and * Roald Hoff-aan John P. Hoidren detailed assessment, they can dangerously undermine U.S. nuclear * -l Robert Horvitz * David H. -
Profile of Gary Ruvkun
PROFILE Profile of Gary Ruvkun wash in the faint glow of a fluo- Brush with Molecular Biology rescent lamp, a pair of serpentine The story of Ruvkun’s metamorphosis Anematode worms lie on a Petri from a keen undergraduate into a leading plate, their see-through bodies light in his field of study begins at Har- magnified 100-fold by one of several vard University, where he enrolled in microscopes arrayed in a darkened bay in a Ph.D. program in 1976 upon returning National Academy of Sciences member to the United States. Like many other Gary Ruvkun’s laboratory at Massachu- scientific institutions across the world in setts General Hospital. While one of the the mid-1970s, Harvard was astir with the worms wiggles its way around the plate, promise of recombinant DNA technol- the other shows no signs of life, ogy, and Ruvkun wasted no time em- its midsection ruptured and its innards bracing its tools. “My undergraduate strewn asunder. A filter slides into place, education had not prepared me at all for and the worms are bathed in a dull recombinant DNA, but I immersed my- green haze. The wiggling worm has a bea- self into its culture at Harvard, much of con of nerve cells in its head, the ganglia which was James Watson’s creation from lit up by a genetic trick that has rescued a decade earlier,” Ruvkun says. Propelled the worm from death; its neighbor wears Gary Ruvkun. by a desire to be a part of the culture of no such beacon. The worms were deprived basic molecular biology, all while per- of a tiny RNA molecule, called a micro- forming science with the potential to im- RNA, which helps shepherd them through not 5-year-old children. -
The US BRAIN Initiative
The US BRAIN Initiative Brain Research through Advancing Innovative Neurotechnologies John Donoghue, Ph.D. member US BRAIN Geneva Professor Advisory Commi5ee to the NIH Director of Neuroscience Director 1 views expressed here are my own and not those of the US Government Why a US BRAIN Initiative? The Need Is Great § Brain disorders: #1 source of disability in U.S. – > 100 million Americans affected § Rates are increasing § Costs are increasing- § annual cost of dementia ~$200B § by 2050 >$1Trillion § Already equals cost of cancer and heart disease The cost of disorders of the brain in Europe amounts overall to €798 billion in 2010 Eur Neuropsych. (2011) 21, 817-779 WHO, 2008 The Challenge for the 21st Century We do NOT know enough about the brain source: Donoghue! 3 “The Next Great American Project” “So there is this enormous mystery waiPng to be unlocked, and the BRAIN IniPave will change that by giving sciensts the tools they need to get a dynamic picture of the brain in acCon and be5er understand how we think and how we learn and how we remember. And that knowledge could be – will be – transformave.” -- President Obama, April 2, 2013 4 US BRAIN Initiative “a public and private effort” + Private Investments 5 The NIH BRAIN ScienCfic Plan • NIH Advisory Committee to the Director- William Newsome, PhD (co-chair) Working Group Stanford University (scientists, federal officials) • Met 2013-14 • Broad input from Cornelia Bargmann, PhD scientific community (co-chair) The Rockefeller University • Released June 2014 FIRST FIVE YEARS SECOND FIVE YEARS Emphasize technology Emphasize discovery development driven science 6 Understanding the Brain as a SYSTEM To map the circuits of the brain, measure the fluctuang paerns of electrical and chemical acPvity flowing within those circuits, and understand how their interplay creates our unique cogniPve and behavioral capabiliPes. -
2008 Harvard / Paul F
The 2008 Harvard / Paul F. Glenn Symposium on Aging June 23, 2008 Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Welcome to the 3rd Annual Harvard/Paul F. Glenn Symposium on Aging. Each year, the Paul F. Glenn Laboratories host the Harvard Symposium on Aging with a mission to educate the wider research community about advancements in this fast-paced field and to stimulate collaborative research in this area. We have been fortunate to have many of the leaders in the aging field speak at these symposia. As a result, attendees come not only from the Harvard research community but from across the nation and from overseas for this one day event. We are glad you could join us here today. The reasons for accelerating research molecular biology of aging are clear. First and foremost, the number of aged individuals in developed countries is growing rapidly, which is going to place an unprecedented burden on the families and the economies of those nations. Because chronic illness in the elderly is a major medical cost, enormous savings would be achieved if mortality and morbidity could be compressed within a shorter duration of time at the end of life. A study by the RAND Corporation in 2006 concluded that advances in medicine arising from aging research would be 10-100 times more cost-effective than any other medical breakthrough. Advances in aging research have shown that it is possible to extend the healthy lifespan of laboratory animals through genetic and pharmacological means. Many leaders in the aging field predict that significant strides will be made in understanding how human health and lifespan are regulated, leading to novel medicines to forestall and treat diseases of aging such as diabetes, cancer, Alzheimer’s and heart disease. -
Signature Redacted Certified By: __Signature Redacted
Genetic Regulation of Cell Extrusion in Caenorhabditis elegans By Vivek Kumar Dwivedi M. Tech. Biochemical Engineering and Biotechnology Indian Institute of Technology Delhi, 2012 Submitted to the Department of Biology in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy at the Massachusetts Institute of Technology June 2019 2019 Massachusetts Institute of Technology. All rights reserved. The author hereby grants to MIT permission to reproduce and to distribute publicly paper and electronic copies of this thesis document in whole or in part in any medium now known or hereafter created. Signature redacted Signature of Author: Department of Biology, May 28, 2019 Certified by: __Signature redacted H. Roiert Horvitz Professor of Biology Thesis Supervisor Accepted by: Signature redacted MASSACHUSETS INSTITUTE Amy . eag OF TECHNOLOGY- Professor of Biology Graduate Committee MAY 312 Co-Chair, Biology LIBRARIES ARCHIVES 1 Genetic Regulation of Cell Extrusion in Caenorhabditis elegans by Vivek Kumar Dwivedi Submitted to the MIT Department of Biology on May 28, 2019 in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy in Biology Abstract Programmed elimination of cells occurs during animal development and homeostasis to maintain appropriate cell numbers. One evolutionarily conserved method by which organisms eliminate cells in a programmed manner is by cell- autonomous activation of the caspase-mediated apoptosis pathway, which produces a corpse that is engulfed and degraded by phagocytic cells. Cell elimination can also occur by a different method, called cell extrusion, in which the cell to be eliminated is squeezed out from a layer of cells, such as an epithelium. -
Reviewers [PDF]
The Journal of Neuroscience, January 2013, 33(1) Acknowledgement For Reviewers 2012 The Editors depend heavily on outside reviewers in forming opinions about papers submitted to the Journal and would like to formally thank the following individuals for their help during the past year. Kjersti Aagaard Frederic Ambroggi Craig Atencio Izhar Bar-Gad Esther Aarts Céline Amiez Coleen Atkins Jose Bargas Michelle Aarts Bagrat Amirikian Lauren Atlas Steven Barger Lawrence Abbott Nurith Amitai David Attwell Cornelia Bargmann Brandon Abbs Yael Amitai Etienne Audinat Michael Barish Keiko Abe Martine Ammasari-Teule Anthony Auger Philip Barker Nobuhito Abe Katrin Amunts Vanessa Auld Neal Barmack Ted Abel Costas Anastassiou Jesús Avila Gilad Barnea Ute Abraham Beau Ances Karen Avraham Carol Barnes Wickliffe Abraham Richard Andersen Gautam Awatramani Steven Barnes Andrey Abramov Søren Andersen Edward Awh Sue Barnett Hermann Ackermann Adam Anderson Cenk Ayata Michael Barnett-Cowan David Adams Anne Anderson Anthony Azevedo Kevin Barnham Nii Addy Clare Anderson Rony Azouz Scott Barnham Arash Afraz Lucy Anderson Hiroko Baba Colin J. Barnstable Ariel Agmon Matthew Anderson Luiz Baccalá Scott Barnum Adan Aguirre Susan Anderson Stephen Baccus Ralf Baron Geoffrey Aguirre Anuska Andjelkovic Stephen A. Back Pascal Barone Ehud Ahissar Rodrigo Andrade Lars Bäckman Maureen Barr Alaa Ahmed Ole Andreassen Aldo Badiani Luis Barros James Aimone Michael Andres David Badre Andreas Bartels Cheryl Aine Michael Andresen Wolfgang Baehr David Bartés-Fas Michael Aitken Stephen Andrews Mathias Bähr Alison Barth Elias Aizenman Thomas Andrillon Bahador Bahrami Markus Barth Katerina Akassoglou Victor Anggono Richard Baines Simon Barthelme Schahram Akbarian Fabrice Ango Jaideep Bains Edward Bartlett Colin Akerman María Cecilia Angulo Wyeth Bair Timothy Bartness Huda Akil Laurent Aniksztejn Victoria Bajo-Lorenzana Marisa Bartolomei Michael Akins Lucio Annunziato David Baker Marlene Bartos Emre Aksay Daniel Ansari Harriet Baker Jason Bartz Kaat Alaerts Mark S. -
3 and 4/1998 Genetic Engineering and Biotechnology
OCCASION This publication has been made available to the public on the occasion of the 50th anniversary of the United Nations Industrial Development Organisation. DISCLAIMER This document has been produced without formal United Nations editing. The designations employed and the presentation of the material in this document do not imply the expression of any opinion whatsoever on the part of the Secretariat of the United Nations Industrial Development Organization (UNIDO) concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries, or its economic system or degree of development. Designations such as “developed”, “industrialized” and “developing” are intended for statistical convenience and do not necessarily express a judgment about the stage reached by a particular country or area in the development process. Mention of firm names or commercial products does not constitute an endorsement by UNIDO. FAIR USE POLICY Any part of this publication may be quoted and referenced for educational and research purposes without additional permission from UNIDO. However, those who make use of quoting and referencing this publication are requested to follow the Fair Use Policy of giving due credit to UNIDO. CONTACT Please contact [email protected] for further information concerning UNIDO publications. For more information about UNIDO, please visit us at www.unido.org UNITED NATIONS INDUSTRIAL DEVELOPMENT ORGANIZATION Vienna International Centre, P.O. Box 300, 1400 Vienna, Austria Tel: (+43-1) 26026-0 · www.unido.org · [email protected] EMERGING TECHNOLOGY SERIES 3 and 4/1998 Genetic Engineering and Biotechnology UNITED NATIONS INDUSTRIAL DEVELOPMENT ORGANIZATION Vienna, 1999 TO OUR READERS EMERGING TECHNOLOGY SERIES: Globalization, the information society, sustainable development: these are the keywords of the day. -
THE GENOMIC SEQUENCING TECHNIQUE George M. Church
Medical Genetics: Past, Present, Future, pages 17-21 © 1985 Alan R. Llss , Inc. THE GENOMIC SEQUENCING TECHNIQUE George M. Church and Walter Gilbert Biogen Cambridge , Massachusetts 02 142 In a mammalian cell , the DNA corresponding to any gene sequence is surrounded by DNA corr esponding to some million other such sequences. How can we study a specific gene without isolating it away from al l others? We have devised a technfque that will display the se quence of any gene without previous purification (Ch urch and Gilbert 1983) . Our method extends the Southern blotting technique to a new degree of sensitivity . \.J'e use a radioactive probe not just to identify a single r estriction fragment of DNA but as a way of end-labeling a unique restriction fragment. This end- label ing by hybridization is analogous to the end- labeling that we do in the conventional DNA sequencing , which enables us to display in any partial digest a series of fragments extending out f r om the point of label ing as a series of labeled bands separated by size . Although the chemical DNA sequencing techniques usually use onl y a single labeled phosphate, if the hybridization probe is kept moderately short, on the order of 100 nucleotides , it will serve as a end- label that can display sequence running out several hundred bases beyond the end of the probe . We take total DNA and cut it with a restr iction enzyme, one of .whose cuts is close to the sequence of interest. After we perform the chemical sequencing reactions on that total DNA, we electrophorese the ~enatured DNA through a conventional sequencing gel. -
Dr. Paul Janssen Award for Biomedical Research Issues 2015
Press Contacts: Dr. Paul Janssen Award for Biomedical Research Issues Seema Kumar 2015 Call for Nominations 908-405-1144 (M) [email protected] New Brunswick, N.J. – January 21, 2015 – The Dr. Paul Janssen Award for Diane Pressman Biomedical Research today opens its 2015 call for nominations. This prestigious 908-927-6171 (O) award recognizes individuals whose scientific research has made, or has the [email protected] potential to make, significant contributions toward the improvement of human Frederik Wittock health. Nominations will be accepted until March 15, 2015 at +32 14 60 57 24 (O) www.pauljanssenaward.com for consideration by an independent selection [email protected] committee of world renowned scientists. Beginning in 2015, the cash prize awarded to the scientist or group of scientists receiving the Award will be increased to $200,000. This increase in the monetary award reflects the growing importance of basic biomedical research, and continued recognition by Johnson & Johnson of excellence in the field. The Dr. Paul Janssen Award for Biomedical Research honors Dr. Paul Janssen (1926-2003), who is widely recognized as one of the most productive scientists of the 20th century. Known throughout the scientific community as “Dr. Paul,” Janssen was responsible for breakthrough treatments in disease areas including pain management, psychiatry, infectious disease and gastroenterology, and founded Janssen Pharmaceutica, N.V., a Johnson & Johnson Company. “Innovative science and technology have the power to transform the world,” said Paul Stoffels, M.D., Chief Scientific Officer and Worldwide Chairman, Pharmaceuticals, Johnson & Johnson. “Through the Dr. Paul Janssen Award for Biomedical Research, Johnson & Johnson honors the inspirational legacy of Dr. -
Dynamics of Excitatory-Inhibitory Neuronal Networks With
I (X;Y) = S(X) - S(X|Y) in c ≈ p + N r V(t) = V 0 + ∫ dτZ 1(τ)I(t-τ) P(N) = 1 V= R I N! λ N e -λ www.cosyne.org R j = R = P( Ψ, υ) + Mγ (Ψ, υ) σ n D +∑ j n k D k n MAIN MEETING Salt Lake City, UT Feb 27 - Mar 2 ................................................................................................................................................................................................................. Program Summary Thursday, 27 February 4:00 pm Registration opens 5:30 pm Welcome reception 6:20 pm Opening remarks 6:30 pm Session 1: Keynote Invited speaker: Thomas Jessell 7:30 pm Poster Session I Friday, 28 February 7:30 am Breakfast 8:30 am Session 2: Circuits I: From wiring to function Invited speaker: Thomas Mrsic-Flogel; 3 accepted talks 10:30 am Session 3: Circuits II: Population recording Invited speaker: Elad Schneidman; 3 accepted talks 12:00 pm Lunch break 2:00 pm Session 4: Circuits III: Network models 5 accepted talks 3:45 pm Session 5: Navigation: From phenomenon to mechanism Invited speakers: Nachum Ulanovsky, Jeffrey Magee; 1 accepted talk 5:30 pm Dinner break 7:30 pm Poster Session II Saturday, 1 March 7:30 am Breakfast 8:30 am Session 6: Behavior I: Dissecting innate movement Invited speaker: Hopi Hoekstra; 3 accepted talks 10:30 am Session 7: Behavior II: Motor learning Invited speaker: Rui Costa; 2 accepted talks 11:45 am Lunch break 2:00 pm Session 8: Behavior III: Motor performance Invited speaker: John Krakauer; 2 accepted talks 3:45 pm Session 9: Reward: Learning and prediction Invited speaker: Yael